OverviewSuggest Edit

Alliqua BioMedical is a regenerative technologies company which commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing, Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies, and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The Company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

TypePublic
Founded1997
HQMorrisville, US
Websitealliqua.com

Latest Updates

Employees (est.) (Dec 2018)6(-92%)
Revenue (FY, 2016)$18.2 M(+22%)
Share Price (May 2019)$2.7 (+11%)

Key People/Management at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Brian Posner

Brian Posner

CFO
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs
Nino Pionati

Nino Pionati

Chief Strategy and Marketing Officer
Gregory Robb

Gregory Robb

VP Operations
Show more

Alliqua Office Locations

Alliqua has an office in Morrisville
Morrisville, US (HQ)
1010 Stony Hill Rd #200
Show all (1)

Alliqua Financials and Metrics

Alliqua Revenue

Alliqua's revenue was reported to be $18.24 m in FY, 2016 which is a 21.3% increase from the previous period.
USD

Net income (FY, 2018)

(8.4m)

EBIT (FY, 2018)

(5.3m)

Market capitalization (3-May-2019)

13.4m

Closing stock price (3-May-2019)

2.7

Cash (31-Dec-2018)

8.9m
Alliqua's current market capitalization is $13.4 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.8m4.8m15.0m18.2m

Revenue growth, %

166%214%21%

Cost of goods sold

2.1m3.3m6.0m6.7m6.8m1.7m

Gross profit

(299.3k)1.5m9.0m11.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

438.0k

Cost of goods sold

586.7k631.7k836.7k915.8k1.2m1.4m1.7m1.8m1.6m1.8m1.7m1.9m1.5m1.7m593.0k361.0k

Gross profit

(148.7k)

Gross profit Margin, %

(34%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

12.1m16.8m26.1m5.6m2.2m8.9m

Accounts Receivable

156.8k968.6k2.5m2.8m3.2m34.0k

Inventories

501.5k477.8k3.1m2.7m1.6m101.0k

Current Assets

12.8m19.6m32.7m11.8m7.5m9.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

420.2k9.6m23.8m19.9m10.9m35.8m30.7m17.0m12.6m10.7m2.4m2.3m2.1m1.5m11.0m11.1m

Accounts Receivable

144.5k164.1k474.4k715.6k1.4m2.3m2.4m2.5m2.5m2.7m2.9m3.6m2.9m4.0m442.0k172.0k

Inventories

305.7k501.1k940.7k1.1m1.6m2.9m3.5m3.5m3.1m3.2m2.6m2.8m2.0m1.7m139.0k183.0k

Current Assets

955.4k10.5m25.3m22.0m14.8m41.7m37.5m24.1m23.5m17.6m8.3m8.9m7.8m7.6m13.0m12.2m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(22.0m)(25.4m)(26.0m)(28.2m)(25.7m)(8.4m)

Depreciation and Amortization

674.2k2.9m4.2m5.4m1.9m

Inventories

(241.1k)477.8k(1.4m)(113.0k)792.0k(120.0k)

Accounts Payable

174.0k1.8m571.6k(26.0k)(1.0m)(1.4m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

Alliqua Online and Social Media Presence

Embed Graph

Alliqua News and Updates

Alliqua BioMedical CEO Provides Update to Shareholders

LANGHORNE, Pa., April 22, 2019 (GLOBE NEWSWIRE) -- Dear Shareholder:

Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business

LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock outstanding as of the close of business on April 22, 2019 (the “Record Date”), subject…

Thinking about buying stock in Apple, Alliqua BioMedical, Inc., Advanced Micro Devices, Dollar Tree, Inc. or New Age Beverages Corp.?

CHICAGO, Nov. 29, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, ALQA, AMD, DLTR, and NBEV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the…

Alliqua Blogs

Alliqua Biomedical CEO Provides Update to Shareholders

LANGHORNE, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- To our Alliqua Shareholders: I hope you have seen our recent exciting announcements that we believe drove the increase in our market capitalization and liquidity over the past couple of months. Based on the positive response to that news, …

Alliqua Frequently Asked Questions

  • When was Alliqua founded?

    Alliqua was founded in 1997.

  • Who are Alliqua key executives?

    Alliqua's key executives are David Johnson, Brad C. Barton and Brian Posner.

  • How many employees does Alliqua have?

    Alliqua has 6 employees.

  • Who are Alliqua competitors?

    Competitors of Alliqua include TissueTech, Owlstone Medical and Cytori Therapeutics.

  • Where is Alliqua headquarters?

    Alliqua headquarters is located at 1010 Stony Hill Rd #200, Morrisville.

  • Where are Alliqua offices?

    Alliqua has an office in Morrisville.

  • How many offices does Alliqua have?

    Alliqua has 1 office.